您的购物车当前为空
别名 BEY1107 trihydrochloride
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.

Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,280 | 现货 | |
| 5 mg | ¥ 2,820 | 现货 | |
| 10 mg | ¥ 4,480 | 现货 | |
| 25 mg | ¥ 6,930 | 现货 | |
| 50 mg | ¥ 9,330 | 现货 | |
| 100 mg | ¥ 12,600 | 现货 | |
| 200 mg | ¥ 16,800 | 现货 |
| 产品描述 | Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer. |
| 别名 | BEY1107 trihydrochloride |
| 分子量 | 390.65 |
| 分子式 | C13H14Cl3N7O |
| CAS No. | 1983984-01-5 |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多